The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ICML 2019 | Chemo-free in CLL not always the best option
Othman Al-Sawaf, MD, University Hospital of Cologne, Cologne, Germany, gives an insightful perspective into chemotherapy-free regimens for chronic lymphocytic leukemia (CLL). He highlights how chemo-free may not always be the best option. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.
